
Overview
As an Associate Professor and Director of the Gastrointestinal Program in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins School of Medicine, Dr. Meyer's clinical and research focus is on the treatment of gastrointestinal cancers, including rectal, anal, esophageal, pancreatic, and liver malignancies. He is also leading the effort to establish a liver stereotactic body radiation therapy (SBRT) program within the department. Dr. Meyer has experience with clinical research studies in SBRT, as well as radiation and drug combination therapy for cancer. Make A Gift.
Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Cancer.
His clinical research consists of co-authoring 95 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
401 North Broadway Street, Weinberg Building, Floor-L2, Weinberg Building, Floor-L2, Baltimore, MD 21287
401 North Broadway Street, Weinberg BLDG, Floor-L1 (Lobby Level), Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
University Of Maryland Radiation Oncology Associates PA
Vinita Patanaphan is a Radiation Oncologist in Baltimore, Maryland. Dr. Patanaphan is rated as an Advanced provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Prostate Cancer, and Familial Prostate Cancer. Dr. Patanaphan is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Chengcheng Gui is an instructor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. His clinical focus is the use of radiotherapy to treat head and neck cancers, as well as skin cancers. Dr. Gui obtained his medical degree from the Johns Hopkins University School of Medicine and completed his residency training at Memorial Sloan Kettering Cancer Center, where he served as chief resident and received the Radiation Oncology Medical Student Teaching Award. Dr. Gui believes that cancer patients deserve a clear and thorough understanding of the benefits and risks of their treatment options, empowering them to choose the path that best aligns with their personal values. To support this, Dr. Gui is committed to being an approachable, trustworthy source of information, while also planning and delivering high-quality radiotherapy. Research Summary Dr. Gui's research focuses on enhancing the safety and effectiveness of radiotherapy by integrating multiple data modalities. His work incorporates advanced structural and functional imaging, tumor molecular characteristics, and patient-reported outcomes to inform and personalize treatment approaches. Selected Publications Gui C, Wray R, Schöder H, Deasy JO, Grkovski M, Humm JL, Wong RJ, Sherman EJ, Riaz N, Lee NY. Tumor hypoxia on 18F-fluoromisonidazole positron emission tomography and distant metastasis from head and neck squamous cell carcinoma. JAMA Network Open. 2024 Sep 3;7(9):e2436407-. Gui C, Walch H, Mueller K, Boe L, Skakodub A, Miao E, Khatri I, Kumar R, Padilla Mazzeo, Shen J, Cooper C, Parker M, Hsu A, Patel R, Ilica AT, Stember JN, Eichholz JE, Bou Nassif R, Yu KKH, Wilcox JA, Manca P, Yu Y, Yamada Y, Imber BS, Maron SB, Foote MB, Chatila WK, Yaeger R, Schultz N, Pike LRG. Genomics correlates of brain metastasis and progression in colorectal cancer. Neuro-Oncology. 2025 Aug 28:noaf198. doi: 10.1093/neuonc/noaf198. Online ahead of print. Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, Quiñones-Hinojosa A, Redmond KJ. A prospective cohort study of neural progenitor cell-sparing radiation therapy plus temozolomide for newly diagnosed patients with glioblastoma. Neurosurgery. 2020 Jul 1;87(1):E31-40. Redmond KJ, Gui C, Benedict S, Milano MT, Grimm J, Vargo JA, Soltys SG, Yorke E, Jackson A, El Naqa I, Marks LB. Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. International Journal of Radiation Oncology* Biology* Physics. 2021 May 1;110(1):53-67. Eitz KA, Lo SS, Soliman H, Sahgal A, Theriault A, Pinkham MB, Foote MC, Song AJ, Shi W, Redmond KJ, Gui C, Kumar AMS, Machtay M, Meyer B, Combs SE. Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases. JAMA Oncology. 2020 Dec 1;6(12):1901-9. Dr. Gui is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Brain Tumor, Primary Lymphoma of the Brain, Myxoid Liposarcoma, Endoscopy, and Osteotomy.
Wellspan Medical Group
Jeanette Linder is a Radiation Oncologist in Gettysburg, Pennsylvania. Dr. Linder is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Medulloblastoma, Posterior Fossa Tumor, Endometrial Cancer, and Anal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Meyer isDistinguished. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Meyer isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Familial Pancreatic CancerDr. Meyer isDistinguished. Learn about Familial Pancreatic Cancer.
- Advanced
- Fibrolamellar CarcinomaDr. Meyer isAdvanced. Learn about Fibrolamellar Carcinoma.
- Pancreatic CancerDr. Meyer isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Anaplastic Large Cell LymphomaDr. Meyer isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone TumorDr. Meyer isExperienced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Meyer isExperienced. Learn about Epithelioid Sarcoma.
- Familial Prostate CancerDr. Meyer isExperienced. Learn about Familial Prostate Cancer.
- FibrosarcomaDr. Meyer isExperienced. Learn about Fibrosarcoma.
- Follicular LymphomaDr. Meyer isExperienced. Learn about Follicular Lymphoma.
